NYSE:GSK

GlaxoSmithKline Stock Forecast, Price & News

$37.69
+1.56 (+4.32 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$37.59
Now: $37.69
$38.26
50-Day Range
$33.61
MA: $35.66
$36.69
52-Week Range
$33.26
Now: $37.69
$43.18
Volume20.15 million shs
Average Volume6.09 million shs
Market Capitalization$101.48 billion
P/E Ratio11.60
Dividend Yield6.97%
Beta0.67
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; Novartis; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; and CureVac. The company also has an agreement with Vir Biotechnology, Inc for research and development of new therapies for influenza and other respiratory viruses. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
GlaxoSmithKline logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone44-20-8047-5000
Employees99,437
Year Founded2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$43.10 billion
Cash Flow$4.34 per share
Book Value$9.40 per share

Profitability

Net Income$5.93 billion

Miscellaneous

Outstanding Shares2,692,595,000
Market Cap$101.48 billion
Next Earnings Date5/5/2021 (Estimated)
OptionableOptionable

Headlines

GlaxoSmithKline (NYSE:GSK) Sees Strong Trading Volume
April 15, 2021 |  americanbankingnews.com
See More Headlines

MarketRank

Overall MarketRank

1.11 out of 5 stars

Medical Sector

991st out of 2,021 stocks

Pharmaceutical Preparations Industry

461st out of 772 stocks

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$37.69
+1.56 (+4.32 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











GlaxoSmithKline (NYSE:GSK) Frequently Asked Questions

Is GlaxoSmithKline a buy right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 3 sell ratings, 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View analyst ratings for GlaxoSmithKline
or view top-rated stocks.

What stocks does MarketBeat like better than GlaxoSmithKline?

Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but GlaxoSmithKline wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is GlaxoSmithKline's next earnings date?

GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for GlaxoSmithKline
.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (NYSE:GSK) issued its quarterly earnings results on Tuesday, February, 2nd. The pharmaceutical company reported $0.62 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.64 by $0.02. The pharmaceutical company had revenue of $8.74 billion for the quarter, compared to analysts' expectations of $8.71 billion. GlaxoSmithKline had a net margin of 18.50% and a trailing twelve-month return on equity of 29.60%. The firm's quarterly revenue was down 1.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.39 EPS.
View GlaxoSmithKline's earnings history
.

How has GlaxoSmithKline's stock been impacted by Coronavirus?

GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GSK stock has decreased by 5.5% and is now trading at $37.69.
View which stocks have been most impacted by COVID-19
.

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline announced a quarterly dividend on Thursday, February 4th. Stockholders of record on Friday, February 19th will be paid a dividend of $0.628 per share on Thursday, April 8th. This represents a $2.51 dividend on an annualized basis and a dividend yield of 6.66%. The ex-dividend date is Thursday, February 18th. This is a positive change from GlaxoSmithKline's previous quarterly dividend of $0.50.
View GlaxoSmithKline's dividend history
.

Is GlaxoSmithKline a good dividend stock?

GlaxoSmithKline pays an annual dividend of $2.52 per share and currently has a dividend yield of 6.97%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. GlaxoSmithKline does not yet have a strock track record of dividend growth. The dividend payout ratio of GlaxoSmithKline is 79.50%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GlaxoSmithKline will have a dividend payout ratio of 81.82% in the coming year. This indicates that GlaxoSmithKline may not be able to sustain their current dividend.
View GlaxoSmithKline's dividend history.

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the following people:
  • Ms. Emma N. Walmsley, CEO & Director (Age 51)
  • Mr. Iain James Mackay, CFO & Exec. Director (Age 59)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 58)
  • Ms. Karenann K. Terrell, Chief Digital & Technology Officer (Age 59)
  • Ms. Sarah Elton-Farr, Head of Investor Relations
  • Mr. Nick Hirons, Sr. VP of Global Ethics & Compliance
  • Mr. James Ford, Sr. VP & Gen. Counsel
  • Ms. Sally Jackson, Sr. VP of Global Communications & CEO Office
  • Ms. Diana Conrad, Sr. VP of HR
  • Mr. David Simon Redfern, Chief Strategy Officer (Age 55)

Who are some of GlaxoSmithKline's key competitors?

What other stocks do shareholders of GlaxoSmithKline own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA).

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK."

Who are GlaxoSmithKline's major shareholders?

GlaxoSmithKline's stock is owned by many different institutional and retail investors. Top institutional investors include Welch & Forbes LLC (0.02%), Jacobs & Co. CA (0.01%), Farmers Trust Co. (0.01%), Pacer Advisors Inc. (0.00%), Signature Wealth Management Group (0.00%) and Old Port Advisors (0.00%).
View institutional ownership trends for GlaxoSmithKline
.

Which major investors are selling GlaxoSmithKline stock?

GSK stock was sold by a variety of institutional investors in the last quarter, including Ipswich Investment Management Co. Inc., City Holding Co., Crossmark Global Holdings Inc., Loring Wolcott & Coolidge Fiduciary Advisors LLP MA, Chemung Canal Trust Co., Pacer Advisors Inc., First Bank & Trust, and Optimum Investment Advisors.
View insider buying and selling activity for GlaxoSmithKline
or view top insider-selling stocks.

Which major investors are buying GlaxoSmithKline stock?

GSK stock was purchased by a variety of institutional investors in the last quarter, including Park National Corp OH, Boothe Investment Group Inc., Marotta Asset Management, Jacobs & Co. CA, Ballew Advisors Inc, Hohimer Wealth Management LLC, KG&L Capital Management LLC, and Farmers Trust Co..
View insider buying and selling activity for GlaxoSmithKline
or or view top insider-buying stocks.

How do I buy shares of GlaxoSmithKline?

Shares of GSK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately $37.69.

How much money does GlaxoSmithKline make?

GlaxoSmithKline has a market capitalization of $101.48 billion and generates $43.10 billion in revenue each year. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis.

How many employees does GlaxoSmithKline have?

GlaxoSmithKline employs 99,437 workers across the globe.

When was GlaxoSmithKline founded?

GlaxoSmithKline was founded in 2000.

What is GlaxoSmithKline's official website?

The official website for GlaxoSmithKline is www.gsk.com.

Where are GlaxoSmithKline's headquarters?

GlaxoSmithKline is headquartered at 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]


This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.